Quadrant licenses imaging portfolio to Upperton:
This article was originally published in Clinica
UK development-stage imaging contrast agent company Upperton has licensed patents and assignments from fellow UK company Quadrant Healthcare. Upperton says that the intellectual property will enable it to proceed rapidly on a number of key projects, including MRI and ultrasound imaging. Quadrant is a drug delivery company developing spray- and vacuum-dried saccharide coated glass nanoparticles whose shell erosion allows for time release drug delivery. In June, it divested three of its imaging patent portfolio to Acuson and licensed products for in vitro diagnostics to Becton Dickinson.